Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/26 17:35 | 7/6/26 | DYN | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | 7 | S.m | -63,911 | 20.60 | 0 | -3,103 | 1,286 | I | ||||||||||||||||
6/26/26 16:15 | 6/25/26 | DYN | Health | Drug | Pharmaceutical Preparations | Lucera Erick | MA | O | CFO | 2 | S | -75 | 19.61 | 0 | -4 | 124 | D | |||||||||||||||
6/24/26 16:27 | 6/22/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | D | 4 | S.m | -14,195 | 20.38 | 0 | -697 | 4,208 | I | ||||||||||||||||
6/17/26 16:08 | 6/16/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 2 | S | -45 | 18.35 | 0 | -2 | 170 | D | |||||||||||||||
6/17/26 16:07 | 6/16/26 | DYN | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 2 | S | -7 | 18.35 | 0 | 0 | 0 | 154 | D | ||||||||||||||
6/17/26 16:07 | 6/16/26 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 2 | S | -110 | 18.35 | 0 | -6 | 443 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |